Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Rontis Hellas S.A.
WARNING LETTER
•Rontis Hellas S.A.•July 25, 2024

Rontis Hellas S.A. – FDA Warning Letter, Jul 25, 2024

Record Details

An FDA inspection of Industrial Area of Larissa, Greece, from July 22-25, 2024, revealed that the firm's Cronus HP PTA OTW Balloon Catheter devices are adulterated and misbranded. The devices are adulterated under 21 U.S.C. § 351(h) due to non-conformity with Quality System regulation 21 CFR Part 820, specifically a failure to validate processes with a high degree of assurance as required by 21 CFR 820.75(a). This included issues with EtO sterilization validation, such as performing validation without EtO gas, inadequate justification for product selection, and undocumented product adoption. The devices are also misbranded under 21 U.S.C. § 352(t)(2) for failing to furnish required Medical Device Reporting (MDR) information per 21 CFR Part 803. The firm's written MDR procedures (RC_SOP-10-003) were found inadequate, lacking internal systems for timely event identification, evaluation, and communication (21 CFR 803.17(a)(1)), a standardized review process (21 CFR 803.17(a)(2)), and timely transmission of complete reports (21 CFR 803.17(a)(3)). Furthermore, documentation and recordkeeping requirements were not adequately addressed (21 CFR 803.17(b)). Despite revisions, the procedure continued to fail in establishing timely identification/evaluation and transmission systems. Critically, the firm lacked an active ESG production account for electronic MDR submissions. The FDA deemed the firm's responses inadequate and requires a written response within fifteen business days detailing corrective actions, prevention plans, and a timeline for systemic improvements. Failure to comply may impact federal contracts and Class III device approvals.

Company
Rontis Hellas S.A.
Inspection date
July 25, 2024
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Bram D. Zuckerman
  • Jessica Osward-McLeod
View Company Profile

ID · fb493dba-5c2c-4745-ae9a-566cb82a4711

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 80321 CFR 803.1721 CFR 803.17(a)(1)21 CFR 803.17(a)(2)21 CFR 803.17(a)(3)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rontis Hellas S.A.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.